Tislelizumab in People With Colorectal Cancer
Tislelizumab in People With Colorectal Cancer
Recruiting · NCT06529523 · Registry updated 2026-09-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Tislelizumab in People With Colorectal Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder | Recruiting | Phase 2 | 2026-09-17 | NCT06529523 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| BeOne Medicines | 76 |
| Memorial Sloan Kettering Cancer Center | 753 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Lagos University Teaching Hospital | Idi-Araba | Nigeria | 2 |
| Memorial Sloan Kettering Cancer Center | New York | United States | 1000 |
| Obafemi Awolowo University Teaching Hospital | Ile-Ife | Nigeria | 1 |